TITLE

Study: Drugs get more for their ad bucks

AUTHOR(S)
Snyder, Beth
PUB. DATE
March 1999
SOURCE
Advertising Age;3/22/1999, Vol. 70 Issue 12, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article asserts that pharmaceutical marketers spend less on advertising but get more brand recognition, while automobile-related advertisers spend the most but get the least brand recognition, based from the study conducted by Corporate Branding in the U.S. in 1999. The study pitted the advertising support for pharmaceuticals, automobiles, computers, financial services and electronic marketers against CoreBrand Power, the consultancy's proprietary consumer research about the strength of a particular brand. The other categories surveyed were: Commercial banks and diversified financial services, computer, software and office equipment companies and electronic and electrical equipment companies.
ACCESSION #
1692744

 

Related Articles

  • Sleep, Diet Awaken as Pharma Regroups. Edwards, Jim // Brandweek;6/20/2005, Vol. 46 Issue 25, pS60 

    Presents updates on brands in the pharmaceutical industry in the U.S. as of June 2005. Impact of the market withdrawals of Merck's Vioxx and Pfizer's Bextra on the industry; Increase in advertising spending in the sleep and diet categories; Development of a voluntary code of conduct for...

  • Bloggers Mumble; Gardasil Starts Buzz. Edwards, Jim // Brandweek;6/18/2007, Vol. 48 Issue 25, pS55 

    The article discusses the best performing brands in the pharmaceutical/prescription drug industry based upon their financial performance, media/advertising spending, and brand identification. The article also examines some of the marketing trends being used by the various brands in the market....

  • Revitalised ginseng tea brand makes good on its revamp. Liu, Christy // Media: Asia's Media & Marketing Newspaper;12/12/2003, p21 

    Pharmaceutical giant Shenzhen Taitai dominated the TV recall chart for November in Hong Kong, as its two sub-brands, Eagle's American Ginseng Tea and Tai Tai Beauty Essence ranked the first and second spot in the chart, as of December 12, 2003. The company's marketing manager, Paul Leung, said...

  • Then There Were Two: Is Detroit Dead? Miller, Steve // Brandweek;6/18/2007, Vol. 48 Issue 25, pS18 

    The article discusses the best performing brands in the automobile industry based upon their financial performance, media/advertising spending, and brand identification. The article also examines some of the marketing trends being used by the various brands in the market. According to the...

  • China automobile market goes into overdrive. Evans, David // Media: Asia's Media & Marketing Newspaper;12/12/2003, p30 

    The article reports that as private consumers take the step into car ownership, automakers are gearing up for major advertising spending increases to lure them to their brands. China's red-hot automobile sector saw category spend surge by almost 105% this year over 2002, underlining the intense...

  • Toyota courts kids with Scion, gets thumbs-up verdict: The box rocks. Rechtin, Mark // Automotive News;10/29/2007 Supplement, Vol. 82, p172 

    The article presents information on the newly introduced small car brand Scion xB, by Toyota Motor Corp. The new brand created credibility with young buyers who did not want their parents' Camry. The Scion xB, ended up doing wonders for generating youthful interest in Toyota through its...

  • Price Tag Panic. Estevez, Matthew // Latin Trade (English);Feb2001, Vol. 9 Issue 2, p21 

    Discusses issues concerning the pricing of brand name drugs in Latin America. Annual income of the company that manufacture Taxol, a prescribed drug for lung, ovarian and breast cancer.

  • Brand Watch. Roller, Kim; Frederick, James // Drug Store News;5/22/2000, Vol. 22 Issue 7, p22 

    Reports on issues related to branded drugs in the United States as of May 22, 2000. Marketing clearance granted to Novartis Pharmaceuticals company, for Exelon or rivastigmine tartrate; Approval for Lantus, an insulin glargine injection for the treatment of diabetes; Approval for Zyvox or...

  • 'Quality of life' brands call for fresh thinking. Coburn, Drew // Medical Marketing & Media;Sep2003, Vol. 38 Issue 9, p106 

    Examines the notion of branding in the pharmaceutical industry in the United States. Quality of life (QOL) brands; Tips to building QOL brands; Issues to be addressed in the process of developing branding strategies.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics